Quick answer: University of Maryland researchers combined toxin-blocking proteins from western diamondback rattlesnake blood to neutralize venom from several dangerous snake species. The mixtures were about 10 times more potent than a current commercial antivenom in laboratory tests, suggesting a promising direction for future snakebite treatments.
A new rattlesnake blood antivenom approach has delivered promising laboratory results by using the snakes’ own defenses against venom. Researchers at the University of Maryland combined naturally occurring toxin-blocking proteins and found that the mixtures were about 10 times more potent than a current commercial antivenom in lab tests.
The proteins come from western diamondback rattlesnakes, which evolved these defenses to protect themselves from venom. In the experiments, combinations of the proteins powerfully neutralized venom from several dangerous snake species, pointing toward a possible new direction for snakebite treatment.
The study was led by Sean B. Carroll, a Distinguished University Professor of Biology at the University of Maryland, and published in the Proceedings of the National Academy of Sciences. The findings concern laboratory performance, rather than an established new treatment for snakebite patients.
How rattlesnakes’ natural defenses could help
The approach starts with a biological advantage rattlesnakes already possess: proteins in their blood that block toxins. Rather than relying on the antibody-production process used for conventional antivenoms, the researchers investigated combinations of these protective proteins.
“This is one of those great stories when nature has already solved a problem we’ve been grappling with for decades,” said Carroll.
The combination of proteins is central to the finding. The researchers achieved unusually strong protection by bringing specific proteins together, with the resulting mixtures acting against venom from more than one dangerous snake species.
That breadth matters because venom contains different toxins, and existing antivenoms do not necessarily work equally well against the toxins found across different species. The reported results offer a promising starting point, but they do not establish that the mixtures work against every kind of snake venom.
What the tenfold result actually means
The headline number is a comparison of potency in laboratory tests: the protein mixtures proved about 10 times more potent than one current commercial antivenom. It is not a comparison with every available antivenom, nor does it demonstrate a tenfold improvement in survival among people bitten by snakes.
Keeping that distinction clear is essential to understanding the discovery. The research points toward potentially more powerful, nature-inspired treatments; the result described is a laboratory finding, not evidence of a replacement already available to patients.
Why better snakebite treatments are needed
Snakebite is considered one of the world’s most neglected tropical diseases. The World Health Organization estimates that venomous snakes kill between 80,000 and 140,000 people each year, while hundreds of thousands of survivors are left with permanent disabilities.
Many affected people live in rural areas where effective antivenom can be difficult to obtain. The need for better treatments therefore extends beyond potency alone: access remains a major part of the snakebite challenge.
Current antivenoms save lives, but their production has significant limitations. They are typically made by exposing large animals to snake venom and collecting the antibodies those animals produce in response.
Manufacturing can be expensive, and the quality and effectiveness of these treatments can vary. Existing antivenoms can also cause serious immune reactions, adding another concern to their use.
The rattlesnake-protein findings offer researchers a different route to explore. For now, the strongest supported conclusion is focused but encouraging: combinations of the snakes’ natural toxin-blocking proteins delivered powerful venom neutralization in the laboratory, with potential to inform future antivenom development.
Frequently Asked Questions
What did scientists discover in rattlesnake blood?
Researchers identified combinations of naturally occurring toxin-blocking proteins in western diamondback rattlesnake blood that powerfully neutralized venom from several dangerous snake species. The snakes evolved these proteins as protection against venom.
How powerful was the rattlesnake blood antivenom in testing?
The protein mixtures were about 10 times more potent than a current commercial antivenom in laboratory tests. That finding does not establish the same improvement in human treatment outcomes or a comparison with all existing antivenoms.
Who led the rattlesnake antivenom research?
Sean B. Carroll, a Distinguished University Professor of Biology at the University of Maryland, led the study. The research was published in the Proceedings of the National Academy of Sciences.
